{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:37:11Z","timestamp":1761950231852,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.resinv.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:22:57Z","timestamp":1681791777000},"page":"438-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5718-5120","authenticated-orcid":false,"given":"Yasutaka","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-4053","authenticated-orcid":false,"given":"Jiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shionoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-4250","authenticated-orcid":false,"given":"Yuri","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-8968","authenticated-orcid":false,"given":"Yuichiro","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-3495","authenticated-orcid":false,"given":"Yuji","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2023.03.009_bib1","unstructured":"Coronavirus pandemic (COVID-19). https:\/\/ourworldindata.org\/coronavirus. [accessed 28 Janunary 2022]."},{"key":"10.1016\/j.resinv.2023.03.009_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-021-27668-9","article-title":"National identity predicts public health support during a global pandemic","volume":"13","author":"Van Bavel","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2023.03.009_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2023.03.009_bib4","article-title":"Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia","volume":"1","author":"Pizzorno","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.resinv.2023.03.009_bib5","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1093\/cid\/ciac014","article-title":"Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study","volume":"1","author":"Marrone","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2023.03.009_bib6","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2023.03.009_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jinf.2021.02.023","article-title":"In-vitro evaluation of the immunomodulatory effects of Baricitinib: implication for COVID-19 therapy","volume":"82","author":"Petrone","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2023.03.009_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaci.2020.08.031","article-title":"Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19","volume":"147","author":"Sims","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2023.03.009_bib9","unstructured":"COVID-19 treatment guidelines. National Institute of Health. https:\/\/www.covid19treatmentguidelines.nih.gov\/management\/clinical-management\/hospitalized-adults-therapeutic-management\/[accessed 28 January 2022]."},{"key":"10.1016\/j.resinv.2023.03.009_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-Barrier): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2023.03.009_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.resinv.2021.07.004","article-title":"Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19","volume":"59","author":"Izumo","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2023.03.009_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102108","article-title":"Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia","volume":"72","author":"Isaka","year":"2022","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resinv.2023.03.009_bib13","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2023.03.009_bib14","first-page":"419","article-title":"Lung volumes in healthy nonsmoking adults","volume":"18","author":"Crapo","year":"1982","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.resinv.2023.03.009_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13679-021-00448-8","article-title":"Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care","volume":"10","author":"Sattar","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.resinv.2023.03.009_bib17","unstructured":"The Japanese Association for Infectious Diseases. Therapy for COVID-19 version 12. (Japanese). https:\/\/www.kansensho.or.jp\/modules\/topics\/index.php?content_id=31. [accessed 28 Janunary 2022]."},{"key":"10.1016\/j.resinv.2023.03.009_bib18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s43440-021-00234-2","article-title":"Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases","volume":"73","author":"Verbic","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.resinv.2023.03.009_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/eri.11.56","article-title":"Immunomodulatory therapy for severe influenza","volume":"9","author":"Darwish","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.resinv.2023.03.009_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/cc10082","article-title":"Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus","volume":"15","author":"Kil","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.resinv.2023.03.009_bib21","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1093\/cid\/ciab875","article-title":"Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort","volume":"1","author":"Mozaffari","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2023.03.009_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2023.03.009_bib23","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30088","article-title":"Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach","volume":"152","author":"Noetzlin","year":"2022","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.resinv.2023.03.009_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/thx.2005.051029","article-title":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease","volume":"61","author":"Baker","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2023.03.009_bib25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534523000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534523000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:32:24Z","timestamp":1761949944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534523000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2212534523000394"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2023.03.009","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}